Related Experiment Video
Updated: Aug 23, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Borderline ovarian tumors: key points and workshop summary
Steven G Silverberg1, Debra A Bell, Robert J Kurman
1Department of Pathology, University of Maryland School of Medicine, Baltimore 21201, USA.
Abstract:
This article documents major points of agreement and disagreement among experts invited to participate in a Borderline Ovarian Tumor Workshop held in Bethesda, MD, on August 27-28, 2003. It is suggested that controversies related to the diagnosis and management of these tumors are often related to lack of data in the literature (small numbers of cases, unreported or unclear criteria for diagnosis and follow-up, insufficient length of follow-up, etc), and specific recommendations are made for further investigation and for reporting of data in future studies.

